International Diabetes Federation. IDF Diabetes Atlas 11th Edition. 2025.

Tancredi M, Rosengren A, Svensson A-M, Kosiborod M, Pivodic A, Gudbjörnsdottir S, et al. Excess mortality among persons with type 2 diabetes. N Engl J Med. 2015;373(18):1720–32.

Article  CAS  PubMed  Google Scholar 

Khunti K, Ceriello A, Cos X, De Block C. Achievement of guideline targets for blood pressure, lipid, and glycaemic control in type 2 diabetes: a meta-analysis. Diabetes Res Clin Pract. 2018;137:137–48.

Article  PubMed  Google Scholar 

Stratton IM, Adler AI, Neil HAW, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405–12.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Khunti K, Zaccardi F, Amod A, Aroda VR, Aschner P, Colagiuri S, et al. Glycaemic control is still central in the hierarchy of priorities in type 2 diabetes management. Diabetologia. 2025;68(1):17–28.

Article  PubMed  Google Scholar 

Sabaté E. Adherence to long-term therapies: evidence for action: World Health Organization; 2003.

Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A, et al. Interventions for enhancing medication adherence. Cochrane database of systematic reviews. 2014(11).

Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691–705.

Article  PubMed  PubMed Central  Google Scholar 

Khunti K, Seidu S, Kunutsor S, Davies M. Association between adherence to pharmacotherapy and outcomes in type 2 diabetes: a meta-analysis. Diabetes Care. 2017;40(11):1588–96.

Article  PubMed  Google Scholar 

Boonpattharatthiti K, Songkla PN, Chantara J, Koomsri C, Krass I, Chaiyakunapruk N, et al. Prevalence of adherence to oral antidiabetic drugs in patients with type 2 diabetes: a systematic review and meta-analysis. Journal of Diabetes Investigation. 2024;15(11):1614–25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–97.

Article  CAS  PubMed  Google Scholar 

Kardas P, Lewek P, Matyjaszczyk M. Determinants of patient adherence: a review of systematic reviews. Front Pharmacol. 2013;4:91.

Article  PubMed  PubMed Central  Google Scholar 

Aikens JE, Piette JD. Longitudinal association between medication adherence and glycaemic control in type 2 diabetes. Diabet Med. 2013;30(3):338–44.

Article  CAS  PubMed  PubMed Central  Google Scholar 

DiBonaventura M, Wintfeld N, Huang J, Goren A. The association between nonadherence and glycated hemoglobin among type 2 diabetes patients using basal insulin analogs. Patient preference and adherence. 2014:873–82.

Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166(17):1836–41.

Article  PubMed  Google Scholar 

Denicolò S, Reinstadler V, Keller F, Thöni S, Eder S, Heerspink HJ, et al. Non-adherence to cardiometabolic medication as assessed by LC-MS/MS in urine and its association with kidney and cardiovascular outcomes in type 2 diabetes mellitus. Diabetologia. 2024;67(7):1283–94.

Article  PubMed  PubMed Central  Google Scholar 

Juarez DT, Tan C, Davis J, Mau M. Factors affecting sustained medication adherence and its impact on healthcare utilization in patients with diabetes. J Pharm Health Serv Res. 2013;4(2):89–94.

Article  PubMed  PubMed Central  Google Scholar 

Hong JS, Kang HC. Relationship between oral antihyperglycemic medication adherence and hospitalization, mortality, and healthcare costs in adult ambulatory care patients with type 2 diabetes in South Korea. Med Care. 2011;49(4):378–84.

Article  PubMed  Google Scholar 

Chew B-H. Medication adherence on quality of life among adults with type 2 diabetes mellitus: an exploratory analysis on the EDDMQoL study. Qual Life Res. 2015;24:2723–31.

Article  PubMed  Google Scholar 

Chantzaras A, Yfantopoulos J. Association between medication adherence and health-related quality of life of patients with diabetes. Hormones. 2022;21(4):691–705.

Article  PubMed  PubMed Central  Google Scholar 

Majeed A, Rehman M, Hussain I, Imran I, Saleem MU, Saeed H, et al. The impact of treatment adherence on quality of life among type 2 diabetes mellitus patients–Findings from a cross-sectional study. Patient Prefer Adherence. 2021;475–481.

Yang H, Wu F, Gui M, Cheng Y, Zhang L. The role of medication adherence in the association between depressive symptoms and quality of life in older adults with type 2 diabetes mellitus. BMC Geriatr. 2023;23(1):196.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chandran A, Bonafede MK, Nigam S, Saltiel-Berzin R, Hirsch LJ, Lahue BJ. Adherence to insulin pen therapy is associated with reduction in healthcare costs among patients with type 2 diabetes mellitus. Am Health Drug Benefits. 2015;8(3):148.

PubMed  PubMed Central  Google Scholar 

Gregg EW, Pratt A, Owens A, Barron E, Dunbar-Rees R, Slade ET, et al. The burden of diabetes-associated multiple long-term conditions on years of life spent and lost. Nat Med. 2024;30(10):2830–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):230.

Article  PubMed  PubMed Central  Google Scholar 

Ab Rahman N, Lim MT, Thevendran S, Ahmad Hamdi N, Sivasampu S. Medication regimen complexity and medication burden among patients with type 2 diabetes mellitus: a retrospective analysis. Front Pharmacol. 2022;13:808190.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boye KS, Mody R, Lage MJ, Douglas S, Patel H. Chronic medication burden and complexity for US patients with type 2 diabetes treated with glucose-lowering agents. Diabetes Ther. 2020;11(7):1513–25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Khunti K, Chudasama YV, Gregg EW, Kamkuemah M, Misra S, Suls J, et al. Diabetes and multiple long-term conditions: a review of our current global health challenge. Diabetes Care. 2023;46(12):2092–101.

Article  PubMed  PubMed Central  Google Scholar 

Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23(8):1296–310.

Article  CAS  PubMed  Google Scholar 

Coleman CI, Limone B, Sobieraj DM, Lee S, Roberts MS, Kaur R, et al. Dosing frequency and medication adherence in chronic disease. J Manag Care Pharm. 2012;18(7):527–39.

PubMed  PubMed Central  Google Scholar 

de Vries ST, Keers JC, Visser R, de Zeeuw D, Haaijer-Ruskamp FM, Voorham J, et al. Medication beliefs, treatment complexity, and non-adherence to different drug classes in patients with type 2 diabetes. J Psychosom Res. 2014;76(2):134–8.

Article  PubMed  Google Scholar 

Vijayakumar TM, Jayram J, Cheekireddy VM, Himaja D, Teja YD, Narayanasamy D. Safety, efficacy, and bioavailability of fixed-dose combinations in type 2 diabetes mellitus: a systematic updated review. Curr Ther Res Clin Exp. 2017;84:4–9.

Article  PubMed  PubMed Central  Google Scholar 

Quianzon CC, Cheikh IE. History of current non-insulin medications for diabetes mellitus. J Community Hosp Intern Med Perspect. 2012;2(3):19081.

Article  Google Scholar 

Levine R. Sulfonylureas: background and development of the field. Diabetes Care. 1984;7:3–7.

CAS  PubMed  Google Scholar 

Kalra S, Sahay BK, Rao MS. Fixed dose combinations in diabetes: Indian innovation, Indian pride. Indian J Endocrinol Metab. 2012;16(Suppl1):S4–5.

PubMed  PubMed Central  Google Scholar 

Lingvay I, Beetz N, Sennewald R, Schuler-Metz A, Bertulis J, Loley C, et al. Triple fixed-dose combination empagliflozin, linagliptin, and metformin for patients with type 2 diabetes. Postgrad Med. 2020;132(4):337–45.